ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer
ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer
Phase I/II trial shows promising activity of invikafusp alfa in PD-1–resistant GI cancers
Nivolumab plus ipilimumab improves survival results in MSI-H/dMMR metastatic colorectal cancer
Durvalumab and tremelimumab show manageable safety in poor-prognosis HCC